nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE7A—renal system—kidney cancer	0.0206	0.173	CbGeAlD
Flavoxate—PDE7A—kidney—kidney cancer	0.0199	0.167	CbGeAlD
Flavoxate—Antrafenine—PTGS1—kidney cancer	0.0157	0.636	CrCbGaD
Flavoxate—Hyperpyrexia—Paclitaxel—kidney cancer	0.0156	0.0565	CcSEcCtD
Flavoxate—PDE8A—nephron tubule—kidney cancer	0.0142	0.119	CbGeAlD
Flavoxate—PDE8B—gonad—kidney cancer	0.0128	0.108	CbGeAlD
Flavoxate—PDE8A—cortex of kidney—kidney cancer	0.0121	0.102	CbGeAlD
Flavoxate—PDE8A—cardiac atrium—kidney cancer	0.0115	0.097	CbGeAlD
Flavoxate—PDE4D—cortex of kidney—kidney cancer	0.011	0.0924	CbGeAlD
Flavoxate—Antrafenine—PTGS2—kidney cancer	0.00897	0.364	CrCbGaD
Flavoxate—PDE4B—cortex of kidney—kidney cancer	0.00579	0.0487	CbGeAlD
Flavoxate—PDE4B—gonad—kidney cancer	0.00552	0.0464	CbGeAlD
Flavoxate—PDE4B—cardiac atrium—kidney cancer	0.00551	0.0464	CbGeAlD
Flavoxate—Leukopenia—Temsirolimus—kidney cancer	0.00544	0.0197	CcSEcCtD
Flavoxate—Vision blurred—Pazopanib—kidney cancer	0.0054	0.0196	CcSEcCtD
Flavoxate—Leukopenia—Pazopanib—kidney cancer	0.00513	0.0186	CcSEcCtD
Flavoxate—Skin disorder—Temsirolimus—kidney cancer	0.00482	0.0175	CcSEcCtD
Flavoxate—Dry mouth—Pazopanib—kidney cancer	0.00477	0.0173	CcSEcCtD
Flavoxate—Skin disorder—Pazopanib—kidney cancer	0.00454	0.0165	CcSEcCtD
Flavoxate—Somnolence—Temsirolimus—kidney cancer	0.00441	0.016	CcSEcCtD
Flavoxate—Vision blurred—Everolimus—kidney cancer	0.00426	0.0154	CcSEcCtD
Flavoxate—Somnolence—Pazopanib—kidney cancer	0.00416	0.0151	CcSEcCtD
Flavoxate—Vertigo—Vinblastine—kidney cancer	0.00408	0.0148	CcSEcCtD
Flavoxate—Leukopenia—Vinblastine—kidney cancer	0.00406	0.0147	CcSEcCtD
Flavoxate—Leukopenia—Everolimus—kidney cancer	0.00405	0.0147	CcSEcCtD
Flavoxate—Palpitations—Everolimus—kidney cancer	0.004	0.0145	CcSEcCtD
Flavoxate—Dry mouth—Everolimus—kidney cancer	0.00377	0.0136	CcSEcCtD
Flavoxate—Tachycardia—Everolimus—kidney cancer	0.0036	0.0131	CcSEcCtD
Flavoxate—Skin disorder—Everolimus—kidney cancer	0.00358	0.013	CcSEcCtD
Flavoxate—Leukopenia—Sorafenib—kidney cancer	0.00351	0.0127	CcSEcCtD
Flavoxate—Skin disorder—Erlotinib—kidney cancer	0.00346	0.0125	CcSEcCtD
Flavoxate—Leukopenia—Sunitinib—kidney cancer	0.00338	0.0123	CcSEcCtD
Flavoxate—Somnolence—Everolimus—kidney cancer	0.00328	0.0119	CcSEcCtD
Flavoxate—Dry mouth—Sorafenib—kidney cancer	0.00327	0.0118	CcSEcCtD
Flavoxate—Leukopenia—Dactinomycin—kidney cancer	0.0032	0.0116	CcSEcCtD
Flavoxate—Vomiting—Temsirolimus—kidney cancer	0.00315	0.0114	CcSEcCtD
Flavoxate—Dry mouth—Sunitinib—kidney cancer	0.00314	0.0114	CcSEcCtD
Flavoxate—Skin disorder—Sorafenib—kidney cancer	0.00311	0.0113	CcSEcCtD
Flavoxate—Headache—Temsirolimus—kidney cancer	0.00311	0.0113	CcSEcCtD
Flavoxate—Feeling abnormal—Vinblastine—kidney cancer	0.00305	0.0111	CcSEcCtD
Flavoxate—Feeling abnormal—Everolimus—kidney cancer	0.00304	0.011	CcSEcCtD
Flavoxate—Skin disorder—Sunitinib—kidney cancer	0.00299	0.0109	CcSEcCtD
Flavoxate—Vomiting—Pazopanib—kidney cancer	0.00297	0.0108	CcSEcCtD
Flavoxate—Nausea—Temsirolimus—kidney cancer	0.00295	0.0107	CcSEcCtD
Flavoxate—Headache—Pazopanib—kidney cancer	0.00293	0.0106	CcSEcCtD
Flavoxate—Vertigo—Vincristine—kidney cancer	0.00287	0.0104	CcSEcCtD
Flavoxate—Leukopenia—Vincristine—kidney cancer	0.00286	0.0104	CcSEcCtD
Flavoxate—Nausea—Pazopanib—kidney cancer	0.00278	0.0101	CcSEcCtD
Flavoxate—Leukopenia—Gemcitabine—kidney cancer	0.00271	0.00983	CcSEcCtD
Flavoxate—Urticaria—Sorafenib—kidney cancer	0.00254	0.00922	CcSEcCtD
Flavoxate—Tension—Paclitaxel—kidney cancer	0.00249	0.00903	CcSEcCtD
Flavoxate—Nervousness—Paclitaxel—kidney cancer	0.00246	0.00893	CcSEcCtD
Flavoxate—Feeling abnormal—Dactinomycin—kidney cancer	0.0024	0.00872	CcSEcCtD
Flavoxate—Skin disorder—Gemcitabine—kidney cancer	0.0024	0.00871	CcSEcCtD
Flavoxate—Vision blurred—Paclitaxel—kidney cancer	0.00239	0.00867	CcSEcCtD
Flavoxate—Vomiting—Vinblastine—kidney cancer	0.00236	0.00854	CcSEcCtD
Flavoxate—Vomiting—Everolimus—kidney cancer	0.00235	0.00851	CcSEcCtD
Flavoxate—Headache—Vinblastine—kidney cancer	0.00232	0.00841	CcSEcCtD
Flavoxate—Headache—Everolimus—kidney cancer	0.00231	0.00838	CcSEcCtD
Flavoxate—Vertigo—Paclitaxel—kidney cancer	0.00228	0.00826	CcSEcCtD
Flavoxate—Leukopenia—Paclitaxel—kidney cancer	0.00227	0.00823	CcSEcCtD
Flavoxate—Vomiting—Erlotinib—kidney cancer	0.00226	0.00821	CcSEcCtD
Flavoxate—Palpitations—Paclitaxel—kidney cancer	0.00224	0.00813	CcSEcCtD
Flavoxate—Headache—Erlotinib—kidney cancer	0.00223	0.00809	CcSEcCtD
Flavoxate—Nausea—Vinblastine—kidney cancer	0.0022	0.00798	CcSEcCtD
Flavoxate—Somnolence—Gemcitabine—kidney cancer	0.0022	0.00797	CcSEcCtD
Flavoxate—Nausea—Everolimus—kidney cancer	0.00219	0.00795	CcSEcCtD
Flavoxate—Nausea—Erlotinib—kidney cancer	0.00212	0.00767	CcSEcCtD
Flavoxate—Dry mouth—Paclitaxel—kidney cancer	0.00211	0.00766	CcSEcCtD
Flavoxate—Confusional state—Paclitaxel—kidney cancer	0.00209	0.00757	CcSEcCtD
Flavoxate—Feeling abnormal—Gemcitabine—kidney cancer	0.00204	0.00739	CcSEcCtD
Flavoxate—Vomiting—Sorafenib—kidney cancer	0.00204	0.00738	CcSEcCtD
Flavoxate—Tachycardia—Paclitaxel—kidney cancer	0.00202	0.00733	CcSEcCtD
Flavoxate—Skin disorder—Paclitaxel—kidney cancer	0.00201	0.00729	CcSEcCtD
Flavoxate—Headache—Sorafenib—kidney cancer	0.00201	0.00727	CcSEcCtD
Flavoxate—Vision blurred—Capecitabine—kidney cancer	0.00196	0.00711	CcSEcCtD
Flavoxate—Vomiting—Sunitinib—kidney cancer	0.00196	0.0071	CcSEcCtD
Flavoxate—Headache—Sunitinib—kidney cancer	0.00193	0.007	CcSEcCtD
Flavoxate—Eosinophilia—Doxorubicin—kidney cancer	0.00191	0.00691	CcSEcCtD
Flavoxate—Nausea—Sorafenib—kidney cancer	0.0019	0.0069	CcSEcCtD
Flavoxate—Vertigo—Capecitabine—kidney cancer	0.00187	0.00678	CcSEcCtD
Flavoxate—Leukopenia—Capecitabine—kidney cancer	0.00186	0.00676	CcSEcCtD
Flavoxate—Vomiting—Dactinomycin—kidney cancer	0.00186	0.00673	CcSEcCtD
Flavoxate—Somnolence—Paclitaxel—kidney cancer	0.00184	0.00667	CcSEcCtD
Flavoxate—Palpitations—Capecitabine—kidney cancer	0.00184	0.00667	CcSEcCtD
Flavoxate—Nausea—Sunitinib—kidney cancer	0.00183	0.00664	CcSEcCtD
Flavoxate—Dry mouth—Capecitabine—kidney cancer	0.00173	0.00628	CcSEcCtD
Flavoxate—Nausea—Dactinomycin—kidney cancer	0.00173	0.00628	CcSEcCtD
Flavoxate—Drowsiness—Doxorubicin—kidney cancer	0.00172	0.00623	CcSEcCtD
Flavoxate—Confusional state—Capecitabine—kidney cancer	0.00171	0.00621	CcSEcCtD
Flavoxate—Feeling abnormal—Paclitaxel—kidney cancer	0.00171	0.00619	CcSEcCtD
Flavoxate—Tachycardia—Capecitabine—kidney cancer	0.00166	0.00601	CcSEcCtD
Flavoxate—Vomiting—Vincristine—kidney cancer	0.00166	0.00601	CcSEcCtD
Flavoxate—Skin disorder—Capecitabine—kidney cancer	0.00165	0.00598	CcSEcCtD
Flavoxate—Urticaria—Paclitaxel—kidney cancer	0.00165	0.00596	CcSEcCtD
Flavoxate—Headache—Vincristine—kidney cancer	0.00163	0.00592	CcSEcCtD
Flavoxate—Vomiting—Gemcitabine—kidney cancer	0.00157	0.0057	CcSEcCtD
Flavoxate—Headache—Gemcitabine—kidney cancer	0.00155	0.00562	CcSEcCtD
Flavoxate—Nausea—Vincristine—kidney cancer	0.00155	0.00561	CcSEcCtD
Flavoxate—Nausea—Gemcitabine—kidney cancer	0.00147	0.00533	CcSEcCtD
Flavoxate—Feeling abnormal—Capecitabine—kidney cancer	0.0014	0.00508	CcSEcCtD
Flavoxate—Urticaria—Capecitabine—kidney cancer	0.00135	0.00489	CcSEcCtD
Flavoxate—Tension—Doxorubicin—kidney cancer	0.00132	0.00477	CcSEcCtD
Flavoxate—Vomiting—Paclitaxel—kidney cancer	0.00132	0.00477	CcSEcCtD
Flavoxate—Nervousness—Doxorubicin—kidney cancer	0.0013	0.00473	CcSEcCtD
Flavoxate—Headache—Paclitaxel—kidney cancer	0.0013	0.0047	CcSEcCtD
Flavoxate—Vision blurred—Doxorubicin—kidney cancer	0.00126	0.00459	CcSEcCtD
Flavoxate—Nausea—Paclitaxel—kidney cancer	0.00123	0.00446	CcSEcCtD
Flavoxate—Vertigo—Doxorubicin—kidney cancer	0.00121	0.00437	CcSEcCtD
Flavoxate—Leukopenia—Doxorubicin—kidney cancer	0.0012	0.00435	CcSEcCtD
Flavoxate—Palpitations—Doxorubicin—kidney cancer	0.00119	0.0043	CcSEcCtD
Flavoxate—Dry mouth—Doxorubicin—kidney cancer	0.00112	0.00405	CcSEcCtD
Flavoxate—Confusional state—Doxorubicin—kidney cancer	0.0011	0.004	CcSEcCtD
Flavoxate—Vomiting—Capecitabine—kidney cancer	0.00108	0.00392	CcSEcCtD
Flavoxate—Tachycardia—Doxorubicin—kidney cancer	0.00107	0.00388	CcSEcCtD
Flavoxate—Headache—Capecitabine—kidney cancer	0.00106	0.00386	CcSEcCtD
Flavoxate—Skin disorder—Doxorubicin—kidney cancer	0.00106	0.00386	CcSEcCtD
Flavoxate—Nausea—Capecitabine—kidney cancer	0.00101	0.00366	CcSEcCtD
Flavoxate—Somnolence—Doxorubicin—kidney cancer	0.000974	0.00353	CcSEcCtD
Flavoxate—Feeling abnormal—Doxorubicin—kidney cancer	0.000903	0.00327	CcSEcCtD
Flavoxate—Urticaria—Doxorubicin—kidney cancer	0.00087	0.00315	CcSEcCtD
Flavoxate—Vomiting—Doxorubicin—kidney cancer	0.000697	0.00252	CcSEcCtD
Flavoxate—Headache—Doxorubicin—kidney cancer	0.000686	0.00249	CcSEcCtD
Flavoxate—Nausea—Doxorubicin—kidney cancer	0.000651	0.00236	CcSEcCtD
Flavoxate—PDE4D—Signaling by GPCR—IL2—kidney cancer	0.0002	0.000345	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.0002	0.000345	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—kidney cancer	0.0002	0.000344	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—kidney cancer	0.000197	0.000339	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MYC—kidney cancer	0.000197	0.000339	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MYC—kidney cancer	0.000197	0.000339	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—RAF1—kidney cancer	0.000197	0.000339	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PTEN—kidney cancer	0.000196	0.000338	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000194	0.000334	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—IL2—kidney cancer	0.000194	0.000334	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KIT—kidney cancer	0.000193	0.000332	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APC—kidney cancer	0.000193	0.000332	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MAPK1—kidney cancer	0.000192	0.000331	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MAPK1—kidney cancer	0.000192	0.000331	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HIF1A—kidney cancer	0.000191	0.000329	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—VEGFA—kidney cancer	0.000191	0.000328	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL2—kidney cancer	0.000191	0.000328	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TSC2—kidney cancer	0.00019	0.000328	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000189	0.000326	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—MAPK3—kidney cancer	0.000185	0.000318	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—kidney cancer	0.000184	0.000316	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KDR—kidney cancer	0.000182	0.000314	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—KRAS—kidney cancer	0.000182	0.000313	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—KRAS—kidney cancer	0.000182	0.000313	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HIF1A—kidney cancer	0.000182	0.000313	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—BRAF—kidney cancer	0.000181	0.000313	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TSC2—kidney cancer	0.000181	0.000312	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MAPK3—kidney cancer	0.00018	0.00031	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—kidney cancer	0.000177	0.000305	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—VEGFA—kidney cancer	0.000177	0.000305	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL2—kidney cancer	0.000176	0.000304	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—MAPK1—kidney cancer	0.000176	0.000303	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MYC—kidney cancer	0.000175	0.000302	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000174	0.000299	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KDR—kidney cancer	0.000174	0.000299	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKAP13—kidney cancer	0.000173	0.000299	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CASP2—kidney cancer	0.000173	0.000299	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MAPK1—kidney cancer	0.000172	0.000295	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CASP2—kidney cancer	0.000171	0.000295	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKAP13—kidney cancer	0.000171	0.000295	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—PIK3CA—kidney cancer	0.000168	0.00029	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APC—kidney cancer	0.000168	0.000289	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KIT—kidney cancer	0.000168	0.000289	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HIF1A—kidney cancer	0.000168	0.000289	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TSC2—kidney cancer	0.000168	0.000289	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MAPK3—kidney cancer	0.000168	0.000289	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PIK3CA—kidney cancer	0.000167	0.000288	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—PIK3CA—kidney cancer	0.000167	0.000288	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—KRAS—kidney cancer	0.000166	0.000286	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MYC—kidney cancer	0.000163	0.000281	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—KRAS—kidney cancer	0.000162	0.000279	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—kidney cancer	0.000162	0.000278	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—kidney cancer	0.000162	0.000278	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—MAPK3—kidney cancer	0.000161	0.000277	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KDR—kidney cancer	0.000161	0.000277	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—kidney cancer	0.00016	0.000276	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APC—kidney cancer	0.00016	0.000275	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KIT—kidney cancer	0.00016	0.000275	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MAPK1—kidney cancer	0.000159	0.000275	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GRB7—kidney cancer	0.000159	0.000273	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—BRAF—kidney cancer	0.000158	0.000272	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GRB7—kidney cancer	0.000156	0.00027	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—MAPK3—kidney cancer	0.000153	0.000264	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—MAPK1—kidney cancer	0.000153	0.000264	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—PIK3CA—kidney cancer	0.000153	0.000263	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—kidney cancer	0.000152	0.000262	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RAF1—kidney cancer	0.000152	0.000261	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RELA—kidney cancer	0.000151	0.00026	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—KRAS—kidney cancer	0.000151	0.000259	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—BRAF—kidney cancer	0.00015	0.000259	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ERBB2—kidney cancer	0.00015	0.000258	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PIK3CA—kidney cancer	0.000149	0.000256	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KIT—kidney cancer	0.000148	0.000255	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APC—kidney cancer	0.000148	0.000255	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MTOR—kidney cancer	0.000148	0.000255	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ITPR2—kidney cancer	0.000147	0.000254	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—PIK3CA—kidney cancer	0.000146	0.000252	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—MAPK1—kidney cancer	0.000146	0.000251	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ITPR2—kidney cancer	0.000145	0.000251	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—KRAS—kidney cancer	0.000145	0.000249	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—kidney cancer	0.000144	0.000248	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—MAPK3—kidney cancer	0.000142	0.000244	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—kidney cancer	0.000141	0.000243	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—PIK3CA—kidney cancer	0.000139	0.00024	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BRAF—kidney cancer	0.000139	0.00024	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CDKN1B—kidney cancer	0.000139	0.000239	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PIK3CA—kidney cancer	0.000138	0.000238	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—KRAS—kidney cancer	0.000138	0.000237	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—kidney cancer	0.000136	0.000234	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—MAPK1—kidney cancer	0.000135	0.000232	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—kidney cancer	0.000134	0.000231	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CTNNA1—kidney cancer	0.000134	0.00023	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PIK3CA—kidney cancer	0.000133	0.000229	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HSPB1—kidney cancer	0.000133	0.000229	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EIF4EBP1—kidney cancer	0.000133	0.000229	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCND1—kidney cancer	0.000132	0.000228	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—JUN—kidney cancer	0.000132	0.000228	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	0.000132	0.000227	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RAF1—kidney cancer	0.000132	0.000227	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RELA—kidney cancer	0.000131	0.000226	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HSPB1—kidney cancer	0.000131	0.000226	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000131	0.000226	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CTNNB1—kidney cancer	0.000131	0.000226	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ERBB2—kidney cancer	0.00013	0.000225	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PIK3CA—kidney cancer	0.000129	0.000222	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MTOR—kidney cancer	0.000129	0.000222	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PTEN—kidney cancer	0.000128	0.00022	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—KRAS—kidney cancer	0.000127	0.000219	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PIK3CA—kidney cancer	0.000126	0.000218	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RAF1—kidney cancer	0.000126	0.000216	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RELA—kidney cancer	0.000125	0.000215	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ERBB2—kidney cancer	0.000124	0.000214	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSMD7—kidney cancer	0.000124	0.000213	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSC1—kidney cancer	0.000124	0.000213	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ANXA1—kidney cancer	0.000124	0.000213	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MTOR—kidney cancer	0.000123	0.000211	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ANXA1—kidney cancer	0.000122	0.00021	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSC1—kidney cancer	0.000122	0.00021	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSMD7—kidney cancer	0.000122	0.00021	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CDKN1B—kidney cancer	0.000121	0.000208	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FLT1—kidney cancer	0.00012	0.000206	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—kidney cancer	0.000118	0.000204	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FLT1—kidney cancer	0.000118	0.000203	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PIK3CA—kidney cancer	0.000117	0.000202	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RAF1—kidney cancer	0.000116	0.0002	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RELA—kidney cancer	0.000116	0.000199	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—kidney cancer	0.000115	0.000199	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCND1—kidney cancer	0.000115	0.000199	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—JUN—kidney cancer	0.000115	0.000198	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDKN1B—kidney cancer	0.000115	0.000198	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ERBB2—kidney cancer	0.000115	0.000198	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CTNNB1—kidney cancer	0.000114	0.000197	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MTOR—kidney cancer	0.000113	0.000195	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—kidney cancer	0.000113	0.000194	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—kidney cancer	0.000113	0.000194	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—kidney cancer	0.000111	0.000192	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTEN—kidney cancer	0.000111	0.000192	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JUNB—kidney cancer	0.000111	0.000191	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PAK1—kidney cancer	0.000111	0.000191	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCND1—kidney cancer	0.00011	0.000189	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—JUN—kidney cancer	0.000109	0.000189	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PAK1—kidney cancer	0.000109	0.000189	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JUNB—kidney cancer	0.000109	0.000189	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAPK3—kidney cancer	0.000109	0.000188	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CTNNB1—kidney cancer	0.000109	0.000187	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDKN1B—kidney cancer	0.000106	0.000183	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—kidney cancer	0.000106	0.000183	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTEN—kidney cancer	0.000106	0.000182	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—kidney cancer	0.000104	0.000179	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAPK1—kidney cancer	0.000104	0.000179	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—kidney cancer	0.000102	0.000176	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCND1—kidney cancer	0.000102	0.000175	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—JUN—kidney cancer	0.000101	0.000174	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—kidney cancer	0.000101	0.000174	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CTNNB1—kidney cancer	0.000101	0.000173	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—kidney cancer	0.000101	0.000173	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KRAS—kidney cancer	9.81e-05	0.000169	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTEN—kidney cancer	9.8e-05	0.000169	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—kidney cancer	9.57e-05	0.000165	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK3—kidney cancer	9.51e-05	0.000164	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—kidney cancer	9.25e-05	0.000159	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF2—kidney cancer	9.06e-05	0.000156	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK3—kidney cancer	9.05e-05	0.000156	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK1—kidney cancer	9.05e-05	0.000156	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	9.03e-05	0.000155	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CA—kidney cancer	9.02e-05	0.000155	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF2—kidney cancer	8.95e-05	0.000154	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	8.91e-05	0.000153	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—kidney cancer	8.85e-05	0.000152	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—kidney cancer	8.8e-05	0.000152	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1R—kidney cancer	8.76e-05	0.000151	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—kidney cancer	8.72e-05	0.00015	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1R—kidney cancer	8.65e-05	0.000149	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK1—kidney cancer	8.61e-05	0.000148	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KRAS—kidney cancer	8.54e-05	0.000147	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RAF1—kidney cancer	8.45e-05	0.000145	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK3—kidney cancer	8.37e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—kidney cancer	8.34e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RAF1—kidney cancer	8.34e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—kidney cancer	8.23e-05	0.000142	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—kidney cancer	8.14e-05	0.00014	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KRAS—kidney cancer	8.13e-05	0.00014	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK1—kidney cancer	7.97e-05	0.000137	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CA—kidney cancer	7.85e-05	0.000135	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—kidney cancer	7.59e-05	0.000131	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—kidney cancer	7.57e-05	0.00013	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KRAS—kidney cancer	7.52e-05	0.00013	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—kidney cancer	7.47e-05	0.000129	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CA—kidney cancer	7.47e-05	0.000129	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—kidney cancer	7.23e-05	0.000124	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HIF1A—kidney cancer	7.22e-05	0.000124	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSC2—kidney cancer	7.2e-05	0.000124	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HIF1A—kidney cancer	7.12e-05	0.000123	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSC2—kidney cancer	7.1e-05	0.000122	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CA—kidney cancer	6.91e-05	0.000119	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KDR—kidney cancer	6.9e-05	0.000119	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KDR—kidney cancer	6.81e-05	0.000117	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—kidney cancer	6.69e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KIT—kidney cancer	6.36e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APC—kidney cancer	6.36e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APC—kidney cancer	6.27e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KIT—kidney cancer	6.27e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	6.09e-05	0.000105	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—kidney cancer	6.05e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	6.01e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BRAF—kidney cancer	5.97e-05	0.000103	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—kidney cancer	5.97e-05	0.000103	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BRAF—kidney cancer	5.9e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	5.79e-05	9.98e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	5.72e-05	9.85e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	5.53e-05	9.53e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—KRAS—kidney cancer	5.47e-05	9.42e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	5.46e-05	9.41e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—KRAS—kidney cancer	5.4e-05	9.3e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	5.03e-05	8.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RAF1—kidney cancer	4.99e-05	8.59e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RELA—kidney cancer	4.97e-05	8.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	4.96e-05	8.55e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ERBB2—kidney cancer	4.94e-05	8.5e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RAF1—kidney cancer	4.92e-05	8.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RELA—kidney cancer	4.9e-05	8.44e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ERBB2—kidney cancer	4.87e-05	8.39e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MTOR—kidney cancer	4.87e-05	8.39e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MTOR—kidney cancer	4.81e-05	8.28e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	4.57e-05	7.87e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	4.51e-05	7.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—kidney cancer	4.47e-05	7.7e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—kidney cancer	4.42e-05	7.61e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCND1—kidney cancer	4.36e-05	7.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JUN—kidney cancer	4.35e-05	7.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	4.32e-05	7.44e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCND1—kidney cancer	4.3e-05	7.41e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JUN—kidney cancer	4.3e-05	7.4e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	4.26e-05	7.34e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTEN—kidney cancer	4.21e-05	7.25e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTEN—kidney cancer	4.15e-05	7.16e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—kidney cancer	3.8e-05	6.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—kidney cancer	3.75e-05	6.46e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK3—kidney cancer	3.6e-05	6.19e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK3—kidney cancer	3.55e-05	6.11e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—kidney cancer	3.5e-05	6.02e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—kidney cancer	3.45e-05	5.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK1—kidney cancer	3.42e-05	5.89e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK1—kidney cancer	3.38e-05	5.82e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KRAS—kidney cancer	3.23e-05	5.57e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KRAS—kidney cancer	3.19e-05	5.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	2.97e-05	5.11e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	2.93e-05	5.05e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—kidney cancer	2.87e-05	4.95e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—kidney cancer	2.84e-05	4.88e-05	CbGpPWpGaD
